KU-0063794 is a potent and highly specific dual-mTOR inhibitor.

Torkinib is a selective mTOR inhibitor.

Ridaforolimus (Deforolimus, MK-8669) is a selective mTOR inhibitor.

Vistusertib is a novel mTOR inhibitor.

Torin 2 is a potent and selective mTOR inhibitor.

MHY1485 is a potent, and cell-permeable mTOR activator, and also potently inhibits autophagy.

Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.

GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3.